ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gadopentetate Dimeglumine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-9G10352
Home | Market Reports | Health| Pharmacy
Global Gadopentetate Dimeglumine Market Insights Forecast to 2028
BUY CHAPTERS

Global Gadopentetate Dimeglumine Market Research Report 2025

Code: QYRE-Auto-9G10352
Report
July 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
BeiLu Pharma
Consun Pharma

Gadopentetate Dimeglumine Market Size

The global market for Gadopentetate Dimeglumine was valued at US$ 167 million in the year 2024 and is projected to reach a revised size of US$ 265 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Gadopentetate Dimeglumine Market

Gadopentetate Dimeglumine Market

Gadopentetate dimeglumine, also known by the trade name Magnevist, is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) scans to enhance the visibility of blood vessels, organs, and tissues for diagnostic purposes. It is commonly employed to improve the quality and detail of MRI images, aiding in the detection and characterization of various medical conditions.
Market Drivers:
Diagnostic Accuracy: Gadopentetate dimeglumine enhances the contrast between different tissues and structures in MRI scans, leading to improved diagnostic accuracy, better delineation of anatomical features, enhanced visualization of lesions, tumors, and abnormalities, and increased sensitivity in detecting and diagnosing medical conditions, which drives its widespread use in diagnostic imaging.
Medical Imaging Advancements: Technological advancements in MRI equipment, software algorithms, image processing techniques, pulse sequences, and contrast-enhanced imaging protocols have increased the utility and effectiveness of gadopentetate dimeglumine in MRI studies, enhancing image quality, spatial resolution, tissue characterization, diagnostic capabilities, and clinical applications in radiology, neuroimaging, oncology, cardiology, and other medical specialties, driving market demand and adoption rates for contrast-enhanced MRI examinations.
Clinical Utility: Gadopentetate dimeglumine offers clinical utility in various MRI applications, including brain imaging, vascular imaging, musculoskeletal studies, abdominal imaging, liver MRI, breast MRI, cardiac MRI, pediatric imaging, oncologic evaluations, neuroimaging studies, renal MRI, and contrast-enhanced MRI scans, providing valuable diagnostic information, disease assessments, treatment planning insights, functional evaluations, and anatomical details for healthcare providers, radiologists, and medical professionals in patient care, medical diagnostics, and treatment decision-making processes.
Patient Comfort: Gadopentetate dimeglumine is well-tolerated by most patients, has a low incidence of adverse reactions, allergic responses, and side effects, and is considered safe for use in MRI contrast-enhanced studies, contributing to patient comfort, compliance with imaging protocols, patient satisfaction with MRI examinations, and favorable patient experiences in contrast-enhanced MRI procedures, which drive patient acceptance, healthcare provider preference, and market demand for gadolinium-based contrast agents in diagnostic imaging.
Market Competition: Market competition among contrast agent manufacturers, pharmaceutical companies, imaging technology providers, radiology departments, healthcare facilities, diagnostic imaging centers, and healthcare providers fosters product innovation, quality improvements, customer service enhancements, pricing strategies, market differentiation efforts, regulatory compliance measures, marketing initiatives, distribution networks, and market expansion strategies in the gadopentetate dimeglumine market, driving industry dynamics, market growth, technology advancements, and competitive positioning in the contrast-enhanced MRI market segment.
Market Challenges:
Regulatory Compliance: Regulatory compliance challenges, quality control requirements, pharmacovigilance monitoring, safety regulations, labeling standards, packaging guidelines, product approvals, post-market surveillance, adverse event reporting, and compliance with healthcare authorities pose challenges for gadopentetate dimeglumine manufacturers, suppliers, distributors, and healthcare facilities operating in the contrast agent market, necessitating robust regulatory affairs, quality assurance practices, documentation controls, and regulatory compliance strategies to ensure product safety, efficacy, and market authorization.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gadopentetate Dimeglumine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gadopentetate Dimeglumine.
The Gadopentetate Dimeglumine market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gadopentetate Dimeglumine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gadopentetate Dimeglumine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gadopentetate Dimeglumine Market Report

Report Metric Details
Report Name Gadopentetate Dimeglumine Market
Accounted market size in year US$ 167 million
Forecasted market size in 2031 US$ 265 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 10ml: 4.69g
  • 12ml: 5.63g
  • 15ml: 7.04g
  • Others
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, BeiLu Pharma, Consun Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gadopentetate Dimeglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gadopentetate Dimeglumine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Gadopentetate Dimeglumine Market growing?

Ans: The Gadopentetate Dimeglumine Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Gadopentetate Dimeglumine Market size in 2031?

Ans: The Gadopentetate Dimeglumine Market size in 2031 will be US$ 265 million.

Who are the main players in the Gadopentetate Dimeglumine Market report?

Ans: The main players in the Gadopentetate Dimeglumine Market are Bayer, BeiLu Pharma, Consun Pharma

What are the Application segmentation covered in the Gadopentetate Dimeglumine Market report?

Ans: The Applications covered in the Gadopentetate Dimeglumine Market report are Hospitals, Clinics

What are the Type segmentation covered in the Gadopentetate Dimeglumine Market report?

Ans: The Types covered in the Gadopentetate Dimeglumine Market report are 10ml: 4.69g, 12ml: 5.63g, 15ml: 7.04g, Others

Recommended Reports

MRI Systems & Equipment

Contrast Agents Market

Medical Imaging Solutions

1 Gadopentetate Dimeglumine Market Overview
1.1 Product Definition
1.2 Gadopentetate Dimeglumine by Type
1.2.1 Global Gadopentetate Dimeglumine Market Value Comparison by Type (2024 VS 2031)
1.2.2 10ml: 4.69g
1.2.3 12ml: 5.63g
1.2.4 15ml: 7.04g
1.2.5 Others
1.3 Gadopentetate Dimeglumine by Application
1.3.1 Global Gadopentetate Dimeglumine Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Gadopentetate Dimeglumine Market Size Estimates and Forecasts
1.4.1 Global Gadopentetate Dimeglumine Revenue 2020-2031
1.4.2 Global Gadopentetate Dimeglumine Sales 2020-2031
1.4.3 Global Gadopentetate Dimeglumine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gadopentetate Dimeglumine Market Competition by Manufacturers
2.1 Global Gadopentetate Dimeglumine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gadopentetate Dimeglumine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gadopentetate Dimeglumine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gadopentetate Dimeglumine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gadopentetate Dimeglumine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gadopentetate Dimeglumine, Product Type & Application
2.7 Global Key Manufacturers of Gadopentetate Dimeglumine, Date of Enter into This Industry
2.8 Global Gadopentetate Dimeglumine Market Competitive Situation and Trends
2.8.1 Global Gadopentetate Dimeglumine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gadopentetate Dimeglumine Players Market Share by Revenue
2.8.3 Global Gadopentetate Dimeglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gadopentetate Dimeglumine Market Scenario by Region
3.1 Global Gadopentetate Dimeglumine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gadopentetate Dimeglumine Sales by Region: 2020-2031
3.2.1 Global Gadopentetate Dimeglumine Sales by Region: 2020-2025
3.2.2 Global Gadopentetate Dimeglumine Sales by Region: 2026-2031
3.3 Global Gadopentetate Dimeglumine Revenue by Region: 2020-2031
3.3.1 Global Gadopentetate Dimeglumine Revenue by Region: 2020-2025
3.3.2 Global Gadopentetate Dimeglumine Revenue by Region: 2026-2031
3.4 North America Gadopentetate Dimeglumine Market Facts & Figures by Country
3.4.1 North America Gadopentetate Dimeglumine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gadopentetate Dimeglumine Sales by Country (2020-2031)
3.4.3 North America Gadopentetate Dimeglumine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gadopentetate Dimeglumine Market Facts & Figures by Country
3.5.1 Europe Gadopentetate Dimeglumine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gadopentetate Dimeglumine Sales by Country (2020-2031)
3.5.3 Europe Gadopentetate Dimeglumine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gadopentetate Dimeglumine Market Facts & Figures by Region
3.6.1 Asia Pacific Gadopentetate Dimeglumine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gadopentetate Dimeglumine Sales by Region (2020-2031)
3.6.3 Asia Pacific Gadopentetate Dimeglumine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gadopentetate Dimeglumine Market Facts & Figures by Country
3.7.1 Latin America Gadopentetate Dimeglumine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gadopentetate Dimeglumine Sales by Country (2020-2031)
3.7.3 Latin America Gadopentetate Dimeglumine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gadopentetate Dimeglumine Market Facts & Figures by Country
3.8.1 Middle East and Africa Gadopentetate Dimeglumine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gadopentetate Dimeglumine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gadopentetate Dimeglumine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gadopentetate Dimeglumine Sales by Type (2020-2031)
4.1.1 Global Gadopentetate Dimeglumine Sales by Type (2020-2025)
4.1.2 Global Gadopentetate Dimeglumine Sales by Type (2026-2031)
4.1.3 Global Gadopentetate Dimeglumine Sales Market Share by Type (2020-2031)
4.2 Global Gadopentetate Dimeglumine Revenue by Type (2020-2031)
4.2.1 Global Gadopentetate Dimeglumine Revenue by Type (2020-2025)
4.2.2 Global Gadopentetate Dimeglumine Revenue by Type (2026-2031)
4.2.3 Global Gadopentetate Dimeglumine Revenue Market Share by Type (2020-2031)
4.3 Global Gadopentetate Dimeglumine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gadopentetate Dimeglumine Sales by Application (2020-2031)
5.1.1 Global Gadopentetate Dimeglumine Sales by Application (2020-2025)
5.1.2 Global Gadopentetate Dimeglumine Sales by Application (2026-2031)
5.1.3 Global Gadopentetate Dimeglumine Sales Market Share by Application (2020-2031)
5.2 Global Gadopentetate Dimeglumine Revenue by Application (2020-2031)
5.2.1 Global Gadopentetate Dimeglumine Revenue by Application (2020-2025)
5.2.2 Global Gadopentetate Dimeglumine Revenue by Application (2026-2031)
5.2.3 Global Gadopentetate Dimeglumine Revenue Market Share by Application (2020-2031)
5.3 Global Gadopentetate Dimeglumine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Gadopentetate Dimeglumine Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 BeiLu Pharma
6.2.1 BeiLu Pharma Company Information
6.2.2 BeiLu Pharma Description and Business Overview
6.2.3 BeiLu Pharma Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BeiLu Pharma Gadopentetate Dimeglumine Product Portfolio
6.2.5 BeiLu Pharma Recent Developments/Updates
6.3 Consun Pharma
6.3.1 Consun Pharma Company Information
6.3.2 Consun Pharma Description and Business Overview
6.3.3 Consun Pharma Gadopentetate Dimeglumine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Consun Pharma Gadopentetate Dimeglumine Product Portfolio
6.3.5 Consun Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gadopentetate Dimeglumine Industry Chain Analysis
7.2 Gadopentetate Dimeglumine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gadopentetate Dimeglumine Production Mode & Process Analysis
7.4 Gadopentetate Dimeglumine Sales and Marketing
7.4.1 Gadopentetate Dimeglumine Sales Channels
7.4.2 Gadopentetate Dimeglumine Distributors
7.5 Gadopentetate Dimeglumine Customer Analysis
8 Gadopentetate Dimeglumine Market Dynamics
8.1 Gadopentetate Dimeglumine Industry Trends
8.2 Gadopentetate Dimeglumine Market Drivers
8.3 Gadopentetate Dimeglumine Market Challenges
8.4 Gadopentetate Dimeglumine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
BeiLu Pharma
Consun Pharma
List of Tables
 Table 1. Global Gadopentetate Dimeglumine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gadopentetate Dimeglumine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gadopentetate Dimeglumine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gadopentetate Dimeglumine Sales (K L) of Key Manufacturers (2020-2025)
 Table 5. Global Gadopentetate Dimeglumine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gadopentetate Dimeglumine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gadopentetate Dimeglumine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gadopentetate Dimeglumine Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gadopentetate Dimeglumine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gadopentetate Dimeglumine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gadopentetate Dimeglumine, Product Type & Application
 Table 12. Global Key Manufacturers of Gadopentetate Dimeglumine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gadopentetate Dimeglumine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gadopentetate Dimeglumine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gadopentetate Dimeglumine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gadopentetate Dimeglumine Sales by Region (2020-2025) & (K L)
 Table 18. Global Gadopentetate Dimeglumine Sales Market Share by Region (2020-2025)
 Table 19. Global Gadopentetate Dimeglumine Sales by Region (2026-2031) & (K L)
 Table 20. Global Gadopentetate Dimeglumine Sales Market Share by Region (2026-2031)
 Table 21. Global Gadopentetate Dimeglumine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gadopentetate Dimeglumine Revenue Market Share by Region (2020-2025)
 Table 23. Global Gadopentetate Dimeglumine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gadopentetate Dimeglumine Revenue Market Share by Region (2026-2031)
 Table 25. North America Gadopentetate Dimeglumine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gadopentetate Dimeglumine Sales by Country (2020-2025) & (K L)
 Table 27. North America Gadopentetate Dimeglumine Sales by Country (2026-2031) & (K L)
 Table 28. North America Gadopentetate Dimeglumine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gadopentetate Dimeglumine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gadopentetate Dimeglumine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gadopentetate Dimeglumine Sales by Country (2020-2025) & (K L)
 Table 32. Europe Gadopentetate Dimeglumine Sales by Country (2026-2031) & (K L)
 Table 33. Europe Gadopentetate Dimeglumine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gadopentetate Dimeglumine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gadopentetate Dimeglumine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gadopentetate Dimeglumine Sales by Region (2020-2025) & (K L)
 Table 37. Asia Pacific Gadopentetate Dimeglumine Sales by Region (2026-2031) & (K L)
 Table 38. Asia Pacific Gadopentetate Dimeglumine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gadopentetate Dimeglumine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gadopentetate Dimeglumine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gadopentetate Dimeglumine Sales by Country (2020-2025) & (K L)
 Table 42. Latin America Gadopentetate Dimeglumine Sales by Country (2026-2031) & (K L)
 Table 43. Latin America Gadopentetate Dimeglumine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gadopentetate Dimeglumine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gadopentetate Dimeglumine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gadopentetate Dimeglumine Sales by Country (2020-2025) & (K L)
 Table 47. Middle East and Africa Gadopentetate Dimeglumine Sales by Country (2026-2031) & (K L)
 Table 48. Middle East and Africa Gadopentetate Dimeglumine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gadopentetate Dimeglumine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gadopentetate Dimeglumine Sales (K L) by Type (2020-2025)
 Table 51. Global Gadopentetate Dimeglumine Sales (K L) by Type (2026-2031)
 Table 52. Global Gadopentetate Dimeglumine Sales Market Share by Type (2020-2025)
 Table 53. Global Gadopentetate Dimeglumine Sales Market Share by Type (2026-2031)
 Table 54. Global Gadopentetate Dimeglumine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gadopentetate Dimeglumine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gadopentetate Dimeglumine Revenue Market Share by Type (2020-2025)
 Table 57. Global Gadopentetate Dimeglumine Revenue Market Share by Type (2026-2031)
 Table 58. Global Gadopentetate Dimeglumine Price (US$/L) by Type (2020-2025)
 Table 59. Global Gadopentetate Dimeglumine Price (US$/L) by Type (2026-2031)
 Table 60. Global Gadopentetate Dimeglumine Sales (K L) by Application (2020-2025)
 Table 61. Global Gadopentetate Dimeglumine Sales (K L) by Application (2026-2031)
 Table 62. Global Gadopentetate Dimeglumine Sales Market Share by Application (2020-2025)
 Table 63. Global Gadopentetate Dimeglumine Sales Market Share by Application (2026-2031)
 Table 64. Global Gadopentetate Dimeglumine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gadopentetate Dimeglumine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gadopentetate Dimeglumine Revenue Market Share by Application (2020-2025)
 Table 67. Global Gadopentetate Dimeglumine Revenue Market Share by Application (2026-2031)
 Table 68. Global Gadopentetate Dimeglumine Price (US$/L) by Application (2020-2025)
 Table 69. Global Gadopentetate Dimeglumine Price (US$/L) by Application (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Gadopentetate Dimeglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 73. Bayer Gadopentetate Dimeglumine Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. BeiLu Pharma Company Information
 Table 76. BeiLu Pharma Description and Business Overview
 Table 77. BeiLu Pharma Gadopentetate Dimeglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 78. BeiLu Pharma Gadopentetate Dimeglumine Product
 Table 79. BeiLu Pharma Recent Developments/Updates
 Table 80. Consun Pharma Company Information
 Table 81. Consun Pharma Description and Business Overview
 Table 82. Consun Pharma Gadopentetate Dimeglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 83. Consun Pharma Gadopentetate Dimeglumine Product
 Table 84. Consun Pharma Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Gadopentetate Dimeglumine Distributors List
 Table 88. Gadopentetate Dimeglumine Customers List
 Table 89. Gadopentetate Dimeglumine Market Trends
 Table 90. Gadopentetate Dimeglumine Market Drivers
 Table 91. Gadopentetate Dimeglumine Market Challenges
 Table 92. Gadopentetate Dimeglumine Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gadopentetate Dimeglumine
 Figure 2. Global Gadopentetate Dimeglumine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gadopentetate Dimeglumine Market Share by Type: 2024 & 2031
 Figure 4. 10ml: 4.69g Product Picture
 Figure 5. 12ml: 5.63g Product Picture
 Figure 6. 15ml: 7.04g Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Gadopentetate Dimeglumine Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Gadopentetate Dimeglumine Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Global Gadopentetate Dimeglumine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Gadopentetate Dimeglumine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Gadopentetate Dimeglumine Sales (2020-2031) & (K L)
 Figure 15. Global Gadopentetate Dimeglumine Average Price (US$/L) & (2020-2031)
 Figure 16. Gadopentetate Dimeglumine Report Years Considered
 Figure 17. Gadopentetate Dimeglumine Sales Share by Manufacturers in 2024
 Figure 18. Global Gadopentetate Dimeglumine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Gadopentetate Dimeglumine Players: Market Share by Revenue in Gadopentetate Dimeglumine in 2024
 Figure 20. Gadopentetate Dimeglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Gadopentetate Dimeglumine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Gadopentetate Dimeglumine Sales Market Share by Country (2020-2031)
 Figure 23. North America Gadopentetate Dimeglumine Revenue Market Share by Country (2020-2031)
 Figure 24. United States Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Gadopentetate Dimeglumine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Gadopentetate Dimeglumine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Gadopentetate Dimeglumine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Gadopentetate Dimeglumine Revenue Market Share by Region (2020-2031)
 Figure 35. China Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Gadopentetate Dimeglumine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Gadopentetate Dimeglumine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Gadopentetate Dimeglumine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Gadopentetate Dimeglumine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Gadopentetate Dimeglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Gadopentetate Dimeglumine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Gadopentetate Dimeglumine by Type (2020-2031)
 Figure 56. Global Gadopentetate Dimeglumine Price (US$/L) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Gadopentetate Dimeglumine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Gadopentetate Dimeglumine by Application (2020-2031)
 Figure 59. Global Gadopentetate Dimeglumine Price (US$/L) by Application (2020-2031)
 Figure 60. Gadopentetate Dimeglumine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Gadopentetate Dimeglumine API Market Research Report 2024
Global Gadoterate Meglumine Market Research Report 2024
Global Gadopentetic Acid Dimeglumine Salt Injection Market Research Report 2024
Gadolinium Contrast Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gadolinium Contrast Media Market Research Report 2024
Global Gadolinium Contrast Medium Market Research Report 2025
Global Gadodiamide Market Research Report 2024
Global Contrast Agents for Magnetic Resonance Imaging MRI Market Research Report 2024
Global MRI Contrast Agents Market Research Report 2025
Magnetic Resonance Imaging MRI Contrast Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gadolinium based Contrast Media Market Research Report 2024
Global Gadolinium Acetate Market Research Report 2024
Global MRI Contrast Media Agents Market Research Report 2025
Gadolinium III Oxide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Contrast Agent Market Insights Forecast to 2030
Global Tris Tetramethylcyclopentadienyl Gadolinium Market Research Report 2024
Global Contrast Media Injector Market Insights Forecast to 2030
Global Interventional X ray Contrast and Imaging Agents Market Insights Forecast to 2030
Global Gadolinium Acetylacetonate Market Research Report 2024
Global Contrast Medium Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions